コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 humans, rather than endogenous mTERT (mouse telomerase reverse transcriptase).
2 erase RNA; hTER) and the core protein (human telomerase reverse transcriptase).
3 ) decreases the mRNA expression of the human telomerase reverse transcriptase.
4 the MRP ribonucleoprotein ribozyme and human telomerase reverse transcriptase.
5 form stable complexes with the TEN domain of telomerase reverse transcriptase.
6 higher-order multimers of telomerase RNA and telomerase reverse transcriptase.
7 -circle formation in normal cells expressing telomerase reverse transcriptase.
8 he synthesis of the telomeric repeats by the telomerase reverse transcriptase.
9 and T-motif in the RNA-binding domain of the telomerase reverse transcriptase.
10 f two genes, asparagine synthetase and human telomerase reverse transcriptase.
11 nds to a peptide sequence derived from human telomerase reverse transcriptase.
12 tative polymerase chain reaction using human telomerase reverse transcriptase.
13 otide that targets the RNA template of human telomerase reverse transcriptase.
14 The templating RNA is the core of the telomerase reverse transcriptase.
15 and P6.1 to correctly fold and interact with telomerase reverse transcriptase.
16 nts with heterozygous mutations in TERT, the telomerase reverse transcriptase, a 50% reduction in tel
17 ligo also inhibited mRNA expression of human telomerase reverse transcriptase, a catalytic subunit of
20 Telomerases from all organisms contain a telomerase reverse transcriptase and a telomerase RNA (T
21 oblasts transduced with genes encoding human telomerase reverse transcriptase and doxycycline-inducib
22 rmore, we showed that reducing expression of telomerase reverse transcriptase and telomerase activity
24 tations in the genes hTERT and hTR, encoding telomerase reverse transcriptase and telomerase RNA, res
25 ikely to change conformation in complex with telomerase reverse transcriptase and that it provides a
26 tumor antigen vaccine derived from the human telomerase reverse transcriptase and the antiapoptotic p
27 the former encodes the catalytic subunit of telomerase reverse transcriptase and the latter may play
29 nent and the N-terminally biotinylated human telomerase reverse transcriptase and using a newly devel
30 riction decreased expression of hTERT (human telomerase reverse transcriptase) and increased expressi
31 expressed higher levels of K5, CD133, Oct4, telomerase reverse transcriptase, and C-X-C chemokine li
32 iched for expression of Ki-67, ZAP-70, human telomerase reverse transcriptase, and telomerase activit
33 ry, these data suggest that cells expressing telomerase reverse transcriptase are not a progenitor-ce
34 tension (CTE) domain of Arabidopsis thaliana telomerase reverse transcriptase as baits to screen an A
35 d beta1 integrins, DeltaNp63alpha, CD44, and telomerase reverse transcriptase, as well as decreased N
36 ted from chimera mice expressed collagen and telomerase reverse transcriptase but not alpha-smooth mu
37 n) were identified in TERT, the gene for the telomerase reverse transcriptase catalytic enzyme, among
38 ertion in fingers domain" (IFD) in the human telomerase reverse transcriptase catalytic subunit (hTER
39 ll-known "telomere disorder." RMRP binds the telomerase reverse transcriptase (catalytic subunit) in
40 ular and cytogenetic features of the chicken telomerase reverse transcriptase (chTERT) gene and prote
41 it is quickly silenced, specifically due to telomerase reverse transcriptase component (TERT) down-r
42 use myocardium, and transgenic expression of telomerase reverse transcriptase conferred protection fr
43 lmonary fibrosis by activation of fibroblast telomerase reverse transcriptase-dependent proliferation
44 for malignant behavior, expression of human telomerase reverse transcriptase enabled cells from seri
45 lls, whereas interleukin-31 strongly induced telomerase reverse transcriptase expression in fibroblas
46 report that BRCA1 knockdown causes increased telomerase reverse transcriptase expression, telomerase
48 ss various N-terminal fusion proteins of the telomerase reverse transcriptase from its endogenous loc
49 f renal tumor-associated antigens, including telomerase reverse transcriptase, G250, and oncofetal an
50 -Myc can activate transcription of the human telomerase reverse transcriptase gene (hTERT), we addres
52 e hotspot integrations, such as those in the telomerase reverse transcriptase gene (TERT) promoter, a
55 ecruited by Myc to the promoter of the human telomerase reverse transcriptase gene, and p300/CBP stim
56 mice was not affected by inactivation of the telomerase reverse transcriptase gene, indicating that e
57 ome clone containing the entire hTERT (human telomerase reverse transcriptase) gene was introduced in
58 in TERC (telomerase RNA component) and TERT (telomerase reverse transcriptase) have been found in aut
59 When Fancc(-/-) mice were crossed into a telomerase reverse transcriptase heterozygous or null ba
61 therapy, the immunological properties of the telomerase reverse transcriptase hTERT suggest that the
63 the core components of telomerase, the human telomerase reverse transcriptase (hTERT) and associated
64 dopts a new conformation on binding to human telomerase reverse transcriptase (hTERT) and reconstitut
65 LA-DR-restricted peptides derived from human telomerase reverse transcriptase (hTERT) and referred as
67 , the cells were exposed to retroviral human telomerase reverse transcriptase (hTERT) and/or SV40 lar
69 S signaling pathways and activation of human telomerase reverse transcriptase (hTERT) are common in h
70 expression and telomerase activity of human telomerase reverse transcriptase (hTERT) are hallmarks o
71 The mRNA and promoter activities of human telomerase reverse transcriptase (hTERT) are stimulated
73 lects E6-enhanced transcription of the human telomerase reverse transcriptase (hTERT) catalytic subun
74 ce mechanism, ALT+ human fibroblasts require telomerase reverse transcriptase (hTERT) for tumor forma
75 optical methods to measure changes in human telomerase reverse transcriptase (hTERT) gene expression
78 s to and regulates the activity of the human telomerase reverse transcriptase (hTERT) gene promoter.
79 e ectopic expression of telomerase via human telomerase reverse transcriptase (hTERT) gene transfecti
80 so by transcriptionally activating the human telomerase reverse transcriptase (hTERT) gene, which enc
84 increased mRNA expression of CSF1R in human telomerase reverse transcriptase (hTERT) immortalized hu
85 of endogenous human telomerase RNA (hTR) and telomerase reverse transcriptase (hTERT) in HeLa cervica
86 in reaction (RT-PCR) for expression of human telomerase reverse transcriptase (hTERT) in mediastinal
87 to knock down factors cooperating with human telomerase reverse transcriptase (hTERT) in the immortal
88 onal conversion, whereas expression of human telomerase reverse transcriptase (hTERT) induces it.
91 mechanisms governing expression of the human telomerase reverse transcriptase (hTERT) is important fo
96 s of the active full-length isoform of human telomerase reverse transcriptase (hTERT) may be expresse
97 analyses showed that leptin increased human telomerase reverse transcriptase (hTERT) mRNA expression
98 Although Tax impaired induction of human telomerase reverse transcriptase (hTERT) mRNA in respons
99 ,25(OH)(2)VD(3) decreases the level of human telomerase reverse transcriptase (hTERT) mRNA, the catal
101 to show that FTSECs immortalized with human telomerase reverse transcriptase (hTERT) plus SV40 large
102 sid for enhanced tumor transduction, a human telomerase reverse transcriptase (hTERT) promoter for tu
104 s in the regulation of the activity of human telomerase reverse transcriptase (hTERT) promoter in res
105 al system, we recently showed that the human telomerase reverse transcriptase (hTERT) promoter induce
106 tly demonstrated that E6 activates the human telomerase reverse transcriptase (hTERT) promoter via a
109 ing network consistent with a model of human telomerase reverse transcriptase (hTERT) repression in A
110 unction mutations in the TEN-domain of human telomerase reverse transcriptase (hTERT) that disrupt th
111 expressed transcriptional regulator of human telomerase reverse transcriptase (hTERT) that is targete
112 established that hTR remains bound to human telomerase reverse transcriptase (hTERT) throughout all
113 a gene (pRb) and ectopic expression of human telomerase reverse transcriptase (hTERT) to immortalize
114 e we used retroviral overexpression of human telomerase reverse transcriptase (hTERT) to immortalize
116 of Bmi-1 in MECs led to activation of human telomerase reverse transcriptase (hTERT) transcription a
118 atalytic component of human telomerase human telomerase reverse transcriptase (hTERT), and colonies w
119 of p53, transcriptional activation of human telomerase reverse transcriptase (hTERT), and degradatio
120 f human telomerase, telomerase RNA (hTR) and telomerase reverse transcriptase (hTERT), are recruited
121 iated by the induced overexpression of human telomerase reverse transcriptase (hTERT), has permitted
122 The catalytic subunit of telomerase, human telomerase reverse transcriptase (hTERT), is overexpress
123 ng cyclin-dependent kinase (Cdk) 4 and human telomerase reverse transcriptase (hTERT), resulting in c
124 nk between HMGA2 and the regulation of human telomerase reverse transcriptase (hTERT), the catalytic
126 h the transcription and translation of human telomerase reverse transcriptase (hTERT), the catalytic
127 We present evidence that normal and human telomerase reverse transcriptase (hTERT)-immortalized hu
128 Here we characterize the response of human telomerase reverse transcriptase (hTERT)-immortalized no
136 induction of the telomerase component human telomerase reverse transcriptase (hTERT); T cell activat
137 ein catalytic component of telomerase [human telomerase reverse transcriptase (hTERT)] are required f
138 n of the telomerase catalytic subunit [human telomerase reverse transcriptase (hTERT)] expression abr
140 is the transcriptional upregulation of human telomerase reverse transcriptase, hTERT, and the resulta
141 n of the telomerase catalytic subunit (human telomerase reverse transcriptase; hTERT) in human activa
143 1delta) blocks primary ciliogenesis in human telomerase reverse transcriptase immortalized retinal pi
144 orm of CDK4 or knockdown of p16 in the human telomerase reverse transcriptase-immortalized NPE cell l
146 n of TRF2 expression in MNs and knock-out of telomerase reverse transcriptase in NPCs increased their
147 g the catalytic subunit of telomerase (human telomerase reverse transcriptase) in primary human mamma
148 sentation of a universal self-tumor antigen, telomerase reverse transcriptase, in human tumor cells d
149 be mediated through POT1/TRF2 and via human telomerase reverse transcriptase inhibition through JNK
152 the gene encoding its catalytic subunit, the telomerase reverse transcriptase, is established as the
154 s well as the effect that over-expression of telomerase reverse transcriptase may have on the replica
155 ted the 3-prime untranslated region of human telomerase reverse transcriptase mRNA and decreased its
157 ability of 1,25(OH)(2)D(3) to decrease human telomerase reverse transcriptase mRNA and to suppress ov
158 f IRF-4 results in decreased levels of TERT (telomerase reverse transcriptase) mRNA and telomerase ac
159 s and in carcinoma progression, an inducible telomerase reverse transcriptase (mTert) allele was cros
160 ation of slowly cycling ISCs marked by mouse telomerase reverse transcriptase (mTert) expression that
161 tation and telomere dysfunction [produced by telomerase reverse transcriptase (mTERT) gene knockout].
163 ein (GFP), driven by the promoter for murine telomerase reverse transcriptase (mTert), which is a nec
166 oding a 4-hydroxytamoxifen (4-OHT)-inducible telomerase reverse transcriptase-oestrogen receptor (TER
169 of four genetic alterations, including human telomerase reverse transcriptase overexpression, bypass
170 Myc E-box-mediated transactivation and human telomerase reverse transcriptase promoter activity, in a
171 em TTS (TTF1 gene under the control of human telomerase reverse transcriptase promoter and human surf
172 te that Pyk2 is capable of driving the human telomerase reverse transcriptase promoter, resulting in
173 telomerase domain-complementation assays for telomerase reverse transcriptase protein (TERT) and RNA
174 s of two essential components, the catalytic telomerase reverse transcriptase protein (TERT) and the
175 te within its integral RNA subunit (hTR) and telomerase reverse transcriptase protein (TERT) to accom
182 of 5-MeCITP bound to the Tribolium castaneum telomerase reverse transcriptase reveals an atypical int
184 rentiation family), catalytic subunit of rat telomerase reverse transcriptase (rTERT), and proliferat
185 studies utilizing a combination of BRCA1 and telomerase reverse transcriptase small interfering RNAs
186 e first characterize the gene coding for the telomerase reverse transcriptase subunit PpTERT in P. pa
187 d advantages of the TRAIL gene and the human telomerase reverse transcriptase target, Ad/gTRAIL can b
189 HCC, the most frequently mutated genes were telomerase reverse transcriptase (TERT) (58.1%), catenin
190 onucleoprotein telomerase, which comprises a telomerase reverse transcriptase (TERT) and a telomerase
191 ng telomeric repeats using an active site in telomerase reverse transcriptase (TERT) and an integral
192 elomerase, a ribonucleoprotein consisting of telomerase reverse transcriptase (TERT) and an integrall
194 ns two essential components for catalysis, a telomerase reverse transcriptase (TERT) and telomerase R
197 critical for catalytic activity, the protein telomerase reverse transcriptase (TERT) and telomerase R
198 Telomerase minimally comprises the catalytic telomerase reverse transcriptase (TERT) and telomerase R
199 Telomerase contains a catalytic core of telomerase reverse transcriptase (TERT) and telomerase R
201 ' ends of linear chromosomes, using a unique telomerase reverse transcriptase (TERT) and template in
202 ex, the catalytic core of which includes the telomerase reverse transcriptase (TERT) and the non-codi
203 mally consisting of a protein subunit called telomerase reverse transcriptase (TERT) and the telomera
204 ic mutations in the promoter of the gene for telomerase reverse transcriptase (TERT) are the most com
205 telomerase complex is influenced more by the telomerase reverse transcriptase (TERT) binding of the C
206 ls immortalized by the ectopic expression of telomerase reverse transcriptase (TERT) can give rise to
207 nt insights to the noncanonical functions of telomerase reverse transcriptase (TERT) catalytic subuni
208 ve suggested that the core protein mammalian telomerase reverse transcriptase (TERT) component, toget
211 To perform DNA synthesis, the active site of telomerase reverse transcriptase (TERT) copies a templat
212 omerase RNA template, the active site in the telomerase reverse transcriptase (TERT) core, a TERT N-t
214 in lung fibrosis, we examined the effects of telomerase reverse transcriptase (TERT) deficiency in a
215 the overexpression of myocardin (MYOCD) and telomerase reverse transcriptase (TERT) enhanced the sur
218 been previously shown that expression of the telomerase reverse transcriptase (TERT) gene extends the
219 ating mutations occur in the promoter of the telomerase reverse transcriptase (TERT) gene in 66% of m
220 , and point mutations in the promoter of the telomerase reverse transcriptase (TERT) gene increase te
221 ure in MYCN nonamplified neuroblastomas with telomerase reverse transcriptase (TERT) gene overexpress
222 is of B-cell lymphoma DNA confirmed that the telomerase reverse transcriptase (TERT) gene promoter is
224 risk and rs2242652 at 5p15, intronic in the telomerase reverse transcriptase (TERT) gene that encode
225 find a germline deletion in intron 3 of the telomerase reverse transcriptase (TERT) gene that predis
226 tudy, the role of Smad3 in the inhibition of telomerase reverse transcriptase (TERT) gene transcripti
227 ty is characterized by the expression of the telomerase reverse transcriptase (TERT) gene, suggesting
229 ed variants of human telomerase RNA (hTR) or telomerase reverse transcriptase (TERT) have exploited i
230 his study, we extend these observations into telomerase reverse transcriptase (TERT) immortalized ora
231 somatic acquisition of promoter mutations in telomerase reverse transcriptase (TERT) in blood leukocy
232 mplate boundary definition and high affinity telomerase reverse transcriptase (TERT) interaction.
236 ue activity in the catalytic protein subunit telomerase reverse transcriptase (TERT) of telomerase.
237 e downstream network in mice null for either telomerase reverse transcriptase (Tert) or telomerase RN
238 arrow carrying heterozygous mutations in the telomerase reverse transcriptase (TERT) or the telomeras
239 nations of defined tumor-expressed antigens, telomerase reverse transcriptase (TERT) or TRP-2, and VE
240 ct somatic single-nucleotide variants in the telomerase reverse transcriptase (TERT) promoter and iso
245 genes, including MYC transactivation of the telomerase reverse transcriptase (TERT) promoter; and in
246 somes and consists of two main subunits: the telomerase reverse transcriptase (TERT) protein and an a
247 daka and fugu TRs, when assembled with their telomerase reverse transcriptase (TERT) protein counterp
248 ue TR-binding domain (TRBD) in the catalytic telomerase reverse transcriptase (TERT) protein, integra
251 of telomerase-associated proteins other than telomerase reverse transcriptase (TERT) remain ambiguous
253 activity by repressing the catalytic subunit telomerase reverse transcriptase (TERT) through negative
254 determined structures of Tribolium castaneum telomerase reverse transcriptase (TERT) throughout its c
256 ize telomeric repeats, the catalytic subunit telomerase reverse transcriptase (TERT) uses the RNA sub
257 novel alternatively spliced (AS) variants of telomerase reverse transcriptase (TERT) were identified,
258 ver, tumorigenesis-associated genes IGF2 and telomerase reverse transcriptase (TERT) were overexpress
259 vitro with only the telomerase RNA (hTR) and telomerase reverse transcriptase (TERT), additional comp
260 -occurrence of mutations in the promoter for telomerase reverse transcriptase (TERT), along with BRAF
261 on of the catalytic component of telomerase, telomerase reverse transcriptase (TERT), alters sensitiv
262 s a ternary complex of telomerase RNA (TER), telomerase reverse transcriptase (TERT), and the essenti
263 ase RNA and a catalytic protein subunit, the telomerase reverse transcriptase (TERT), as well as seve
264 to mutations in the same genes, such as the telomerase reverse transcriptase (TERT), but through dif
265 RNA (TR) or the catalytic protein component telomerase reverse transcriptase (TERT), cause the genet
266 Regulator of telomere length-1 (RTEL1) and telomerase reverse transcriptase (TERT), genes involved
267 P. tetraurelia telomerase catalytic subunit, telomerase reverse transcriptase (TERT), has been cloned
268 s required for telomere maintenance, such as telomerase reverse transcriptase (TERT), have been found
269 Remarkably, with only binding sites for telomerase reverse transcriptase (TERT), minimized hTR a
270 ically organized by the components, i.e. the telomerase reverse transcriptase (TERT), telomerase RNA
271 often determined by the expression level of telomerase reverse transcriptase (TERT), the catalytic s
272 s exhibiting dysregulated growth may express telomerase reverse transcriptase (TERT), the dual functi
273 endent mutations within the core promoter of telomerase reverse transcriptase (TERT), the gene coding
274 omponents have been identified thus far: the telomerase reverse transcriptase (TERT), the telomerase
275 g an internal RNA template and a specialized telomerase reverse transcriptase (TERT), thereby maintai
276 on of the catalytic component of telomerase, telomerase reverse transcriptase (Tert), which is essent
283 chanistically, ASA treatment upregulates the telomerase reverse transcriptase (TERT)/Wnt/beta-catenin
284 an stem and cancer cells express telomerase [telomerase reverse transcriptase (TERT)] in an effort to
285 Furthermore, an evident up-regulation of telomerase reverse-transcriptase (TERT) expression was d
286 ted the expression of the catalytic subunit (telomerase reverse transcriptase [TERT]) but had no effe
288 , called motif 3, in the catalytic domain of telomerase reverse transcriptase, that is crucial for te
289 east three principal subunits, including the telomerase reverse transcriptase, the telomerase RNA (TE
290 alter the overall stability or expression of telomerase reverse transcriptase, these rare genetic dis
291 NA, which in turn directs the binding of the telomerase reverse transcriptase to form the functional
293 ked with a homology model of the Tetrahymena telomerase reverse transcriptase (tTERT) to characterize
294 sing tissue reconstruction techniques; human telomerase reverse transcriptase was required for cells
296 ficient mutations in TERT, the gene encoding telomerase reverse transcriptase, we asked whether resto
297 xpressed c-kit, interleukin-31 receptor, and telomerase reverse transcriptase when compared with cont
299 amplicon and also encompasses TERT, encoding telomerase reverse transcriptase, which plays a critical